Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
n-(4-hydroxyphenyl)all-trans retinamide (1 trial)
Atrophy (Phase 2)
Geographic Atrophy (Phase 2)
Macular Degeneration (Phase 2)
Trials (1 total)
Trial APIs (1 total)